Entity Common Stock, Shares Outstanding of MiNK Therapeutics, Inc. from Q4 2021 to Q3 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
MiNK Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and change rate from Q4 2021 to Q3 2025.
  • MiNK Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 13 Nov 2025 was 4.69M shares, a 88.1% decline year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

MiNK Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 4.69M -34.9M -88.1% 13 Nov 2025 10-Q 14 Nov 2025
Q2 2025 4.52M -35M -88.6% 12 Aug 2025 10-Q 14 Aug 2025
Q1 2025 3.97M -30.7M -88.6% 13 Mar 2025 10-K 18 Mar 2025
Q3 2024 39.5M +5.03M +14.6% 08 Nov 2024 10-Q 14 Nov 2024
Q2 2024 39.5M +5.03M +14.6% 09 Aug 2024 10-Q 13 Aug 2024
Q1 2024 34.7M +788K +2.33% 15 Mar 2024 10-K 21 Mar 2024
Q3 2023 34.5M +734K +2.17% 03 Nov 2023 10-Q 14 Nov 2023
Q2 2023 34.5M +733K +2.17% 04 Aug 2023 10-Q 10 Aug 2023
Q1 2023 33.9M +353K +1.05% 15 Mar 2023 10-K 24 Mar 2023
Q3 2022 33.8M 31 Oct 2022 10-Q 03 Nov 2022
Q2 2022 33.8M 05 Aug 2022 10-Q 15 Aug 2022
Q1 2022 33.6M 28 Feb 2022 10-K 18 Mar 2022
Q4 2021 33.5M 26 Nov 2021 10-Q 29 Nov 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.